Читать книгу The SAGE Encyclopedia of Stem Cell Research - Группа авторов - Страница 391

While government initiatives for the fight against diabetes are emerging and flourishing, America’s biopharmaceutical research companies also continue to explore various strategies to combat diabetes and its related conditions. Some potential new treatments from the 180 existing medications in development today include enhancing the regeneration of insulin-producing cells (islets) and stimulating the formation of cells capable of generating insulin, a potential state-of-the-art treatment for type 1 diabetes. The treatment would consist of a human peptide made up of the bioactive part of a gene responsible for regenerating pancreatic islets.